Get informed when a big investor buys or sells
+ Follow| P/E Ratio | Dividends | Return on Equity | Price-to-Sales | Debt-to-Equity | ||
|---|---|---|---|---|---|---|
| 0 | - | -47985234% | - | 5.1 | ||
Overvalued by 47.3% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $26.46 Million |
|---|---|
| Enterprise Value | $34.85 Million |
| Earnings per Share | $0 |
| Beta | 1.29 |
| Outstanding Shares | 529,115,272 |
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 3.1 |
| Enterprise Value to EBIT | -13.62 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.28 |
| Debt to Equity | 5.07 |
No data
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 0.00%0% |
|---|---|
| Total Invested | $1,336▼ 13.47% |
| Investors Holding | 10% |
Radnostix, Inc. (INIS) is a company that specializes in the global manufacturing and sale of crucial nuclear medicine calibration and reference standards, cobalt-60 products, and offers contract services for producing radiopharmaceutical...